Alvotech Files Suit Against AbbVie to Invalidate Humira Patent Portfolio

Publication Date13 May 2021
SubjectPatents,Life Sciences,Biosimilars,Patent Litigation,Pharmaceutical Patents,Patent Infringement,AbbVie,Patent Invalidity,Pharmaceutical Industry
AuthorSabrina Poulos
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT